| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 2388.5 | 2392.5 | 2246.7 |
| Other income | 93.7 | 20.2 | 25.8 |
| Total income | 2482.2 | 2412.7 | 2272.5 |
| Profit before exceptional items & tax | 450.3 | 428.3 | 333.1 |
| Exceptional items | 45.8 | -17.6 | 205.1 |
| Profit before tax | 404.4 | 446.0 | 128.0 |
| Net profit | 306.7 | 363.7 | 64.0 |
| Operating margin | 16.3% | 18.5% | 5.6% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +379.20% |
|---|---|
| Net profit, quarter on quarter | -15.70% |
| Revenue, year on year | +6.30% |
BSE results filing, NSE: IPCALAB. Figures extracted from the filing.
Ipca Laboratories Ltd: key numbers
- Share price
- ₹1,945.50
- Market cap
- ₹49,358 Cr
- Revenue (annual)
- ₹9,646 Cr
- Net profit (annual)
- ₹1,141 Cr
- P/E (TTM)
- 37.7×Sector 47.4×
- Promoter holding
- 44.72%+0.00% QoQ
- FII holding
- 10.72%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ipca Laboratories Ltd
All →Ipca Laboratories Earnings Call Transcript: Key Takeaways
Ipca reported strong Q1FY27 with 21% consolidated revenue growth and EBITDA margins expanding 449bps to 22.88%. Management raised full-year growth and margin guidance based on robust generic and domestic performance.
- Call
- Guides 16% growth
Ipca Laboratories Annual General Meeting
Ipca Laboratories held its 76th Annual General Meeting, covering the adoption of financial statements, dividend declaration, and director appointments. No voting results were included.
Ipca Laboratories Q1 FY27 Results: Net Profit ₹424.3 Cr, Up 82.2% YoY
Ipca Laboratories Ltd reported revenue from operations of ₹2,788 Cr (+20.8% YoY) and net profit of ₹424.3 Cr (+82.2% YoY) for Q1 FY27.
- Key figure
- Net profit ₹424.3 Cr · +82.2% YoY
Ipca Laboratories Board Meeting Date
Ipca Laboratories scheduled a Board meeting for August 13, 2026. The board will consider standalone and consolidated financial results for the first quarter.
Ipca Laboratories Dividend
Ipca Laboratories fixed August 7, 2026, as the record date for a Rs. 6 per share dividend. Payment will occur by September 10, 2026.
Ipca Laboratories Annual General Meeting
Ipca Laboratories will hold its 76th AGM on August 13, 2026, via video conferencing. The board recommended a Rs. 6 per share final dividend for shareholders.